CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 302 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00296764
NCT00296764N/ACompleted
CompareCT.gov

Angelman Syndrome Natural History Study

Boston Children's Hospital·observational·Posted Feb 27, 2006·Updated Mar 2, 2021

In Brief

An observational study for Angelman Syndrome. Completed, enrolled 302 participants across 6 sites.

Detailed Summary

Angelman Syndrome (AS) is a developmental disorder that is caused by a deficiency of a maternally transmitted gene. It is inherited at birth, and affects movement, speech, and social demeanor. This study will gain a better understanding of the disease progression and clinical features of AS by observing children with AS over an extended period of time.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAngelman Syndrome
CountriesUnited States
CollaboratorsRady Children's Hospital, San Diego, Baylor College of Medicine, Greenwood Genetic Center, Children's Hospital Medical Center, Cincinnati, Vanderbilt University Medical Center, National Center for Research Resources (NCRR)

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 27, 2006
Enrollment StartFeb 1, 2006
Primary CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 8.5 yearsPosted 20.3 years ago